Concepedia
Statistics
Publications
15
Citations
471
H-Index
Active since
1996
Affiliations
Université de Montréal(Current)
AstraZeneca (Canada)
Novartis (Switzerland)
AstraZeneca (Sweden)
AstraZeneca (United Kingdom)
Malken Bayrakdarian is an author at Université de Montréal specializing in medicinal chemistry, drug discovery, and chemistry.
Publications per year
1996–2014
Total Synthesis of A-315675: A Potent Inhibitor of Influenza Neuraminidase
Stephen Hanessian, Malken Bayrakdarian, Xuehong Luo · Journal of the American Chemical Society · 2002 · 82 citations
Pharmacy, Medicinal Chemistry, Pharmacology +13
Structure-Based Design, Synthesis, and Memapsin 2 (BACE) Inhibitory Activity of Carbocyclic and Heterocyclic Peptidomimetics
Stephen Hanessian, Hongying Yun, Yihua Hou et al. · Journal of Medicinal Chemistry · 2005 · 73 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Structural and NMR Studies of Indenyl Hapticity and Rotational Barriers in the Complexes <b>(</b>η-1-R-Indenyl)Ni(PPh<sub>3</sub>)(X) (R = H, Me; X = Cl, Me)
Trisha A. Huber, Malken Bayrakdarian, Sylvain Dion et al. · Organometallics · 1997 · 59 citations
Natural Sciences, Chemistry, Molecular Physics +10
Discovery of P2X3 selective antagonists for the treatment of chronic pain
Louis‐David Cantin, Malken Bayrakdarian, Christophe Buon et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 31 citations · Full text
Nursing, Medicinal Chemistry, Pharmacology +14
Design, synthesis, and thrombin-inhibitory activity of pyridin-2-ones as P2/P3 core motifs
Stephen Hanessian, Daniel Simard, Malken Bayrakdarian et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 27 citations · Full text
Pharmacy, Chemistry, Medicinal Chemistry +14
1–5 of 15